Search clinical trials for: Non-valvular atrial fibrillation (NVAF)

Total 4420 results

Jordi Gol i Gurina Foundation
Institut Català de la Salut; Department of Health, Generalitat de Catalunya

Unknown

Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation (NACOs)

Atrial Fibrillation | Anticoagulants | Clinical Decision Support Systems

Spain
Bayer
Janssen Research & Development, LLC

Completed

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment (RITMUS-AF)

Non-valvular Atrial Fibrillation

Italy
Ministry of Health, Labour and Welfare, Japan

Unknown

SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF) (SAMURAI-NVAF)

Atrial Fibrillation | Stroke, Acute

Japan
Beijing Friendship Hospital

Recruiting

The Impact of Frailty on Thrombosis of Elderly Patients With NVAF （FTE-NVAF）

Non-valvular Atrial Fibrillation, Elderly, Frailty, Thrombosis

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke (SAFE-PROTECT)

Stroke | Atrial Fibrillation

China
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

The Adherence to Oral Anticoagulant in Chinese Patients With NVAF (NVAF)

Nonvalvular Atrial Fibrillation

China
Pfizer

Completed

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation (CER3)

Non-valvular Atrial Fibrillation

Japan
Pfizer

Withdrawn

Assessment of the Effectiveness and Safety Outcome in Patients With Atrial Fibrillation Treated by Apixaban in Belgium (PROVECT)

Atrial Fibrillation

Belgium
Bayer

Completed

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist (DABI-F)

Atrial Fibrillation

United States
Bayer
Janssen Research & Development, LLC

Completed

Real-world Comparative Effectiveness of Rivaroxaban Versus VKA (RIVA-F)

Atrial Fibrillation

United States
National Hospital Organization Osaka National Hospital
Network for Clinical Stroke Trials; The BMS/Pfizer Japan Thrombosis Investigator...

Recruiting

Optimal Antithrombotic Therapy in Ischemic Stroke Patients With Non-Valvular Atrial Fibrillation and Atherothrombosis (ATIS-NVAF)

Ischemic Stroke | Atrial Fibrillation | Atherothrombosis

Japan
Bayer
Janssen Scientific Affairs, LLC

Completed

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Non-valvular Atrial Fibrillation (NVAF)

Japan
Bayer
Janssen Research & Development, LLC

Completed

Real-world Dosing Patterns of Rivaroxaban in the United States

Atrial Fibrillation

United States
Bayer

Completed

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist (PIXI-F)

Atrial Fibrillation

United States
Bayer
Janssen, LP

Completed

Real-Life Evidence on Stroke Prevention in SPAF (RELIEF)

Atrial Fibrillation (Prevention of Stroke)

Germany
Bristol-Myers Squibb

Withdrawn

Early Post-marketing Study of Eliquis (Apixaban)

Non-valvular Atrial Fibrillation (NVAF)

Mexico
Bayer

Completed

A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin (RENOVATOR)

Non-valvular Atrial Fibrillation (NVAF)

Korea, Republic of
Abbott Medical Devices

Completed

AMPLATZER™ Cardiac Plug Observational Post-Approval Study (ACP China)

Non-valvular Atrial Fibrillation (NVAF)

China
Bristol-Myers Squibb

Completed

A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Non-Valvular Atrial Fibrillation (NVAF)

Japan
Abbott Medical Devices

Recruiting

Amplatzer Amulet China Post Market Study (PMS)

Non-Valvular Atrial Fibrillation

China
Bristol-Myers Squibb

Recruiting

A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation (PRESBUS)

Non-Valvular Atrial Fibrillation (NVAF)

Italy
Bayer
Janssen Research & Development, LLC

Completed

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation (XARENAL)

Non-valvular Atrial Fibrillation (NVAF)

Korea, Republic of
Bayer
Janssen Research & Development, LLC

Completed

Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function (XARETO)

Non-valvular Atrial Fibrillation (NVAF)

Taiwan
Bayer
Janssen Research & Development, LLC

Active, not recruiting

A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF) (XARIN)

Non-valvular Atrial Fibrillation (NVAF)

India
Prof. Dr. med. Ingo Eitel

Recruiting

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease (LAA-KIDNEY)

Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent

Germany
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

Non-valvular Atrial Fibrillation (NVAF) | Acute Coronary Syndrome (ACS)

China
Samsung Medical Center
Bayer

Unknown

Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment (XAIENT)

Renal Insufficiency | Atrial Fibrillation | Elderly | Rivaroxaban

Korea, Republic of
Shenyang Northern Hospital
Beijing Anzhen Hospital; Second Affiliated Hospital of Third Military Medical...

Unknown

Dabigatran Versus Warfarin With NVAF Who Undergo PCI (COACH-AF-PCI)

Coronary Artery Disease | Atrial Fibrillation

China
Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo...

Completed

Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)

Atrial Fibrillation

Thailand
Daiichi Sankyo, Inc.

Completed

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF) (ENSURE-AF)

Atrial Fibrillation

France, Italy, Poland, Ukraine, United Kingdom, United States, Belgium, Germany, Spain, Israel, Bulgaria, Romania, Netherlands, Russian Federation, Austria, Sweden, Hungary, Denmark, Czechia
Duke University
National Institutes of Health (NIH)

Not yet recruiting

Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF

Atrial Fibrillation

United States
Samsung Medical Center

Unknown

Safety and Effectiveness of Low Dose Edoxaban in Patients With NVAF (LEDIOS)

Atrial Fibrillation

Korea, Republic of
Bayer
Janssen Scientific Affairs, LLC

Completed

Use of Direct Oral Anticoagulants in UK

Stroke

United Kingdom
GWT-TUD GmbH
ClinStat GmbH

Completed

Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry (XARENO)

Chronic Kidney Disease (CKD) | Non-valvular Atrial Fibrillation (NVAF)

Germany, Austria, France, Belgium, Switzerland
Bayer
Janssen Research & Development, LLC

Completed

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Atrial Fibrillation

Germany
Bristol-Myers Squibb

Completed

Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US

Nonvalvular Atrial Fibrillation
Japan Cardiovascular Research Foundation

Unknown

GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence (GENeRAL)

Atrial Fibrillation

Japan
Second Affiliated Hospital, School of Medicine,...

Recruiting

Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF (ASAP)

Atrial Fibrillation | Acute Ischemic Stroke

China
Boehringer Ingelheim

Completed

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Atrial Fibrillation

Japan
Bristol-Myers Squibb

Completed

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

Atrial Fibrillation
Bristol-Myers Squibb

Completed

Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Anticoagulation, Blood Thinners , Atrial Fibrillation, Bleeding, Stroke

Spain
Jena University Hospital

Recruiting

Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. (CLEARANCE)

Atrial Fibrillation (AF) | Intracranial Bleed

Germany
Tokai University
Daiichi Sankyo, Inc.

Unknown

Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW) (CMB-NOW)

Ischemic Stroke | Atrial Fibrillation Symptomatic

Japan
Second Affiliated Hospital, School of Medicine,...

Recruiting

Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis (ALLY)

Atrial Fibrillation | Acute Ischemic Stroke | Intracranial Atherosclerosis | Stenosis, Carotid

China
Pfizer

Active, not recruiting

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France (HELIOS-AF)

Atrial Fibrillation

United Kingdom
Pfizer

Completed

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data

Non-valvular Atrial Fibrillation

Japan
M.D. Anderson Cancer Center
Janssen Scientific Affairs, LLC

Completed

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Cancer | Pulmonary Embolism | Non-valvular Atrial Fibrillation | Deep-vein Thrombosis of the Lower and Upper Extremities

United States
Daiichi Sankyo Turkey, a Daiichi Sankyo Company
Daiichi Sankyo, Inc.

Completed

Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (ETAF-TR)

Atrial Fibrillation

Turkey
Bayer

Completed

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care (BEST-AF)

Atrial Fibrillation

United Kingdom
Second Affiliated Hospital, School of Medicine,...
Bayer; The Central Hospital of Lishui City; Shaoxing People's Hospital; Wenzhou... and other collaborators

Recruiting

Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban

Intracranial Hemorrhages | Anticoagulant | Cerebrovascular Stroke | Matrix Metalloproteinases

China

3

Subscribe